The munKNEE Canadian Cannabis LPs Index tracks the performance of the 5 largest vertically integrated (i.e. seed-to-sale) licensed producers by market capitalization. Also presented are links to my summary articles on their latest quarter financial results and a link to a recent article which highlights the financial health of each constituent.

Below is how the constituents performed in 2022, in descending order, and in the month of December:

1. Cronos (CRON): DOWN 35.7% in 2022; DOWN 19.0% in December
   • Read: Cronos Group Q3 Financial Report Disappointing: Stock Declines 10%
2. OrganiGram (OGI): DOWN 55.4% in 2022; DOWN 24.3% in December
   • Read: Organigram Q4 Financial Results: Record Net Revenue; Positive Adjusted EBITDA
3. Tilray (TLRY): DOWN 62.0% in 2022; DOWN 31.0% in December
   • Read: Tilray Brands' Q1 Financials Show Major Improvement Over Previous Quarter
4. Canopy Growth (CGC): DOWN 74.0 % in 2022; DOWN 37.5% in December
   • Read: Canopy Growth Q2 Financial Report: Loss In Net Income Reduced Dramatically
5. Aurora (ACB): DOWN  83.5% in 2022; DOWN 30.5% in December
   • Read: Aurora Cannabis Q1 Financials Show Improvement: Stock Jumps 18%

In total, the munKNEE Canadian Cannabis LPs Index went DOWN 2.6% this week, DOWN 29.3% in December and DOWN 66.0% in all of 2022. That compares favorably, believe it or not, with the munKNEE  American Cannabis MSO Stocks Index which went DOWN 4.1% this week, DOWN 42.6% in December and DOWN 72.7% in all of 2022. 

More By This Author:

Largest Psychedelic Stocks Down 8% Last Week; Down 22% So Far This Month
Cannabis Category Performances Ranged From +0.5% To -17% Last Week
Largest Plant-Based Food Stock Collapse Continues: DOWN 8% This Week